BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Wen-ting He, Yan-hua Zhu, Tong Zhang, Patima Abulimiti, Fan-ye Zeng, Li-ping Zhang, Ling-juan Luo, Xin-mei Xie, Hong-liang Zhang. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-GlycoproteinChinese Journal of Integrative Medicine 2019; 25(6): 416 doi: 10.1007/s11655-018-2997-z
2
Atefeh Satari, Sayed Asadollah Amini, Elham Raeisi, Yves Lemoigne, Esfandiar Heidarian. Synergetic Impact of Combined 5-Fluorouracil and Rutin on Apoptosis in PC3 Cancer Cells through the Modulation of P53 Gene ExpressionAdvanced Pharmaceutical Bulletin 2019; 9(3): 462 doi: 10.15171/apb.2019.055
3
Kanwal Ahmed, Syed Zaidi, Zheng‑Guo Cui, Dejun Zhou, Sheikh Saeed, Hidekuni Inadera. Potential proapoptotic phytochemical agents for the treatment and prevention of colorectal cancer (Review)Oncology Letters 2019;  doi: 10.3892/ol.2019.10349
4
Jose J.G. Marin, Rocio I.R. Macias, Elisa Herraez, Elisa Lozano, Marta R. Romero, Silvia Di Giacomo, Thomas Efferth, Oscar Briz. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy2020; : 197 doi: 10.1016/B978-0-12-816434-1.00007-3
5
Ming Zhang, Ninglin Zhou, Ping Yuan, Yutian Su, Maoni Shao, Cheng Chi. Graphene oxide and adenosine triphosphate as a source for functionalized carbon dots with applications in pH-triggered drug delivery and cell imagingRSC Advances 2017; 7(15): 9284 doi: 10.1039/C6RA27887F
6
Ying-Jie Cui, Chen-Chen Ma, Cheng-Mei Zhang, Long-Qian Tang, Zhao-Peng Liu. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivoEuropean Journal of Medicinal Chemistry 2020; 187: 111968 doi: 10.1016/j.ejmech.2019.111968
7
Min-Li Liu, Feng Zang, Sheng-Jun Zhang. RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC)Biomedicine & Pharmacotherapy 2019; 118: 109250 doi: 10.1016/j.biopha.2019.109250